DE69635407D1 - Hiv-1 der gruppe 0, entsprechende fragmente dieses virus,sowie deren anwendungen - Google Patents

Hiv-1 der gruppe 0, entsprechende fragmente dieses virus,sowie deren anwendungen

Info

Publication number
DE69635407D1
DE69635407D1 DE69635407T DE69635407T DE69635407D1 DE 69635407 D1 DE69635407 D1 DE 69635407D1 DE 69635407 T DE69635407 T DE 69635407T DE 69635407 T DE69635407 T DE 69635407T DE 69635407 D1 DE69635407 D1 DE 69635407D1
Authority
DE
Germany
Prior art keywords
fragments
hiv
group
virus
responsible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69635407T
Other languages
English (en)
Other versions
DE69635407T2 (de
Inventor
Francois Simon
Sentob Saragosti
Ibtissam Loussert-Ajaka
Thoai-Duong Ly
Marie-Laure Chaix-Baudier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Assistance Publique Hopitaux de Paris APHP
Application granted granted Critical
Publication of DE69635407D1 publication Critical patent/DE69635407D1/de
Publication of DE69635407T2 publication Critical patent/DE69635407T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69635407T 1995-02-27 1996-02-26 Hiv-1 der gruppe 0, entsprechende fragmente dieses virus,sowie deren anwendungen Expired - Lifetime DE69635407T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9502236A FR2731013B1 (fr) 1995-02-27 1995-02-27 Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications
FR9502236 1995-02-27
PCT/FR1996/000294 WO1996027013A1 (fr) 1995-02-27 1996-02-26 Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications

Publications (2)

Publication Number Publication Date
DE69635407D1 true DE69635407D1 (de) 2005-12-15
DE69635407T2 DE69635407T2 (de) 2006-08-03

Family

ID=9476523

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635407T Expired - Lifetime DE69635407T2 (de) 1995-02-27 1996-02-26 Hiv-1 der gruppe 0, entsprechende fragmente dieses virus,sowie deren anwendungen

Country Status (9)

Country Link
US (2) US6030769A (de)
EP (1) EP0812359B1 (de)
JP (1) JPH11501805A (de)
AT (1) ATE309365T1 (de)
CA (1) CA2214102C (de)
DE (1) DE69635407T2 (de)
ES (1) ES2256855T3 (de)
FR (1) FR2731013B1 (de)
WO (1) WO1996027013A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19505262C2 (de) * 1995-02-16 1998-06-18 Behring Diagnostics Gmbh Retrovirus aus der HIV-Gruppe und dessen Verwendung
DE69836265T2 (de) * 1997-04-09 2007-05-31 Bio-Rad Pasteur Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o
FR2761993B1 (fr) * 1997-04-09 1999-05-21 Pasteur Sanofi Diagnostics Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 groupe 0
FR2775287B1 (fr) * 1998-02-24 2000-11-24 Pasteur Sanofi Diagnostics Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o
US6511801B1 (en) 1997-07-18 2003-01-28 Innogenetics, N.V. HIV-1 group O antigens and uses thereof
AU2345399A (en) * 1998-01-28 1999-08-16 Universal Health-Watch, Inc. Divergent hiv-1 peptides
CA2288869A1 (en) * 1998-03-04 1999-09-10 Mary Ann Childs Rapid confirmatory test for microbial infections
WO1999062945A2 (en) * 1998-06-05 1999-12-09 Peptide Solutions, Inc. Peptide antigens for detection of hiv, hcv and other microbial infections
CA2676762C (en) * 1998-11-30 2015-12-29 Ortho-Clinical Diagnostics, Inc. Peptides for the detection of hiv-1 group o
NO311807B1 (no) * 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
ATE421999T1 (de) 1999-07-09 2009-02-15 Gen Probe Inc Nachweis von hiv-1 durch amplifizierung von nukleinsäuren
US6582920B2 (en) * 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
FR2869045A1 (fr) * 2004-04-16 2005-10-21 Bioalliance Pharma Sa Methode d'etude de la variabilite genetique et fonctionnelle du vih et kit pour sa mise en oeuvre
WO2006031870A2 (en) * 2004-09-14 2006-03-23 Argos Therapeutics, Inc. Strain independent amplification of pathogens and vaccines thereto
US10113206B2 (en) * 2010-02-24 2018-10-30 Grifols Therapeutics Inc. Methods, compositions, and kits for determining human immunodeficiency virus (HIV)
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Also Published As

Publication number Publication date
ES2256855T3 (es) 2006-07-16
FR2731013A1 (fr) 1996-08-30
US6030769A (en) 2000-02-29
ATE309365T1 (de) 2005-11-15
JPH11501805A (ja) 1999-02-16
EP0812359B1 (de) 2005-11-09
CA2214102C (fr) 2012-01-10
DE69635407T2 (de) 2006-08-03
FR2731013B1 (fr) 1997-05-16
CA2214102A1 (fr) 1996-09-06
US6270975B1 (en) 2001-08-07
WO1996027013A1 (fr) 1996-09-06
EP0812359A1 (de) 1997-12-17

Similar Documents

Publication Publication Date Title
DE69635407D1 (de) Hiv-1 der gruppe 0, entsprechende fragmente dieses virus,sowie deren anwendungen
DE69435126D1 (de) Synthetische humane neutralisierende monoklonale antikörper gegen hiv
ATE380822T1 (de) Funf-helix protein
TR199800327T1 (en) A�ilaminosalisilamidler.
ES2195970T3 (es) L-ribavirina y usos de la misma.
NO2013009I1 (no) Alipogen tiparvovec
DE69111440D1 (de) Methoden und zusammensetzungen zur impfung gegen hiv.
TR199701682T1 (xx) Bir polisakarid konjugat antijen i�eren a�� kompozisyonu.
DE69737683D1 (de) Antikörper gegen die ed-b domäne von fibronektin, ihre herstellung und verwendungen
HN1996000017A (es) Isotiazolonas
NO951212D0 (no) Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus
EP0345462A3 (de) Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde
DK1100789T3 (da) Substituerede benzoylcyclohexandioner
DE3855134D1 (de) Monoklonale menschliche antikörper gegen hiv-i
DK0946731T3 (da) Ikke-M, ikke O HIV-1 stammer, fragmenter og anvendelser
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
DE69841687D1 (de) Erythrovirus und ihre verwendung
ES2088464T3 (es) Uso y administracion de enzimas.
BR0009077A (pt) Antìgenos de tuberculose e métodos de uso dos mesmos
PT633928E (pt) Microrganismos processo de preparacao e utilizacao
ES2115975T3 (es) Derivados de triariletileno utilizados terapeuticamente.
BR9901387A (pt) Composições para a cura de polìmero.
DE69010897D1 (de) Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin.
FR2657882B1 (fr) Fragments d'adn comprenant le gene de la 1-deshydrogenase, micro-organismes transformes par lesdits fragments et applications desdits fragments et micro-organismes.
ES2162123T3 (es) Dihidrato del (2r,3s)-3-terc.-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-10beta-diacetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1-hidroxi-9-oxo-19-nor-ciclopropa(g)tax-11-eno-13alfa-ilo y su procedimiento de preparacion.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: VONNEMANN, KLOIBER & KOLLEGEN, 20099 HAMBURG